Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. Br J Haematol 2021 Sep;194(6):1083-1085
Date
06/09/2021Pubmed ID
34101165DOI
10.1111/bjh.17576Scopus ID
2-s2.0-85107327472 (requires institutional sign-in at Scopus site)Author List
Khan M, Roddy JT, Hernandez JR, Bursch K, Bal N, Carlson KS, Bergl PAAuthor
Karen-Sue B. Carlson MD, PhD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAminopyridines
Enzyme Inhibitors
Humans
Isocitrate Dehydrogenase
Ketosis
Leukemia, Myeloid, Acute
Male
Triazines
